Actively Recruiting
Menstrual Cycle vs. Oral Contraceptives: Effects on Muscle Protein Metabolism After Resistance Exercise
Led by University of Toronto · Updated on 2025-12-02
20
Participants Needed
1
Research Sites
58 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The muscles of the body are constantly breaking down old proteins and building new ones. These two processes, protein breakdown and protein synthesis, together are known as protein turnover. Protein turnover is essential for maintaining healthy muscle. Despite its importance, females have historically been underrepresented in protein metabolism research. A long-standing assumption has been that fluctuations in female sex hormones such as estrogen and progesterone, whether across the natural menstrual cycle or in individuals using oral contraceptives (OCs), make metabolism and training responses too variable to study. Because of this, many researchers have excluded female participants for logistical reasons. Resistance exercise, such as weightlifting, is the most effective way to increase muscle size and strength. Each resistance-training session triggers muscle protein synthesis (MPS), the process by which new muscle proteins are built. Consuming dietary protein or individual amino acids further increases the rate at which new proteins are formed. Over time, higher rates of protein synthesis support muscle growth and the maintenance of other lean tissues in the body. The purpose of this study is to examine how menstrual cycle phases and OC use influence the synthesis of proteins in both muscle tissue and the rest of the body. Improving scientific understanding in this area will support more effective, evidence-based training and nutrition recommendations for females.
CONDITIONS
Official Title
Menstrual Cycle vs. Oral Contraceptives: Effects on Muscle Protein Metabolism After Resistance Exercise
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 40 years
- Body mass index (BMI) between 18.5 and 29.9 kg/m2
- Recreationally active with resistance training at least twice a week
- For oral contraceptive users: using monophasic or triphasic oral contraceptives for more than 1 year
- For non-oral contraceptive users: regular menstrual cycles (21-35 days) for the past 3 months and no hormonal contraceptive use for at least 6 months
- Must pass a progesterone sufficiency test (non-oral contraceptive users)
You will not qualify if you...
- Mid-luteal progesterone levels less than 16 umol
- Diagnosis of chronic diseases such as cardiovascular disease, thyroid disease, or diabetes
- Current or recent remission of cancer
- Regular use of non-steroidal anti-inflammatory drugs (NSAIDs), except low-dose aspirin, or anticoagulants
- Use of prescription drugs affecting muscle protein synthesis, such as statins, lithium, or ADHD medication
- Insertion of intrauterine device (IUD), except copper IUD
- Use of emergency contraception in the last 3 months
- Severe food allergies, including soy or nuts
- Smoking or use of performance-enhancing drugs like growth hormones or testosterone
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Goldring Center for High Performance Sport
Toronto, Ontario, Canada, M5S 2C9
Actively Recruiting
Research Team
D
Daniel R Moore, PhD
CONTACT
I
Ines Kortebi, PhD Candidate
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
BASIC_SCIENCE
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here